{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:21:34Z","timestamp":1792516894073,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Since the mid-1980's there has been a worldwide resurgence of severe disease from group A streptococcus (GAS), with clonal clusters implicated in Europe and the United States. However GAS associated sepsis and rheumatic fever have always remained at high levels in many less developed countries. In this context we aimed to study GAS necrotising fasciitis (NF) in a region where there are high background rates of GAS carriage and disease.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We describe the epidemiology, clinical and laboratory features of 14 consecutive cases of GAS NF treated over a seven year period from tropical northern Australia.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Incidence rates of GAS NF in the Aboriginal population were up to five times those previously published from other countries. Clinical features were similar to those described elsewhere, with 7\/14 (50%) bacteremic and 9\/14 (64%) having associated streptococcal toxic shock syndrome. 11\/14 (79%) had underlying chronic illnesses, including all four fatalities (29% mortality overall). Important laboratory differences from other series were that leukocytosis was absent in 9\/14 (64%) but all had substantial lymphopenia. Sequence typing of the 14 NF-associated GAS isolates showed no clonality, with only one <jats:italic>emm<\/jats:italic> type 1 and two <jats:italic>emm<\/jats:italic> type 3 strains.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>While NF clusters can occur from a single emergent GAS clone, this was not evident in our tropical region, where high rates of NF parallel high overall rates of GAS infection from a wide diversity of strains. The specific virulence factors of GAS strains which do cause NF and the basis of the inadequate host response in those patients who develop NF on infection with these GAS require further elucidation.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2334-4-60","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T15:26:59Z","timestamp":1105630019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature"],"prefix":"10.1186","volume":"4","author":[{"given":"Marilyn","family":"Hassell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,12,16]]},"reference":[{"key":"145_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0002-9610(77)90283-5","volume":"134","author":"A Guiliano","year":"1977","unstructured":"Guiliano A, Lewis F, Hadley K, Blaisdell FW: Bacteriology of necrotizing fasciitis. Am J Surg. 1977, 134: 52-57. 10.1016\/0002-9610(77)90283-5.","journal-title":"Am J Surg"},{"key":"145_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/archsurg.1924.01120080083007","volume":"9","author":"FL Meleney","year":"1924","unstructured":"Meleney FL: Hemolytic streptococcus gangrene. Arch Surg. 1924, 9: 317-364.","journal-title":"Arch Surg"},{"issue":"Suppl 2","key":"145_CR3","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1086\/513851","volume":"179","author":"DL Stevens","year":"1999","unstructured":"Stevens DL: The flesh-eating bacterium: what's next?. J Infect Dis. 1999, 179 (Suppl 2): S366-374.","journal-title":"J Infect Dis"},{"key":"145_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","volume":"344","author":"J Chelsom","year":"1994","unstructured":"Chelsom J, Halstensen A, Haga T, H\u03c6iby EA: Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet. 1994, 344: 1111-1115. 10.1016\/S0140-6736(94)90629-7.","journal-title":"Lancet"},{"key":"145_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0002-9343(97)00160-5","volume":"103","author":"R Kaul","year":"1997","unstructured":"Kaul R, McGeer A, Low DE, Green K, Schwartz B: Population-based surveillance for Group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med. 1997, 103: 18-24. 10.1016\/S0002-9343(97)00160-5.","journal-title":"Am J Med"},{"key":"145_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/00006534-199905000-00003","volume":"103","author":"C Haywood","year":"1999","unstructured":"Haywood C, McGeer A, Low D: Clinical experience with 20 cases of Group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconst Surg. 1999, 103: 1567-1573. 10.1097\/00006534-199905060-00003.","journal-title":"Plast Reconst Surg"},{"key":"145_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0140-6736(92)90339-5","volume":"339","author":"PP Cleary","year":"1992","unstructured":"Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, Schlievert PM: Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980's. Lancet. 1992, 339: 518-21. 10.1016\/0140-6736(92)90339-5.","journal-title":"Lancet"},{"key":"145_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/515114","volume":"28","author":"JR Carapetis","year":"1999","unstructured":"Carapetis JR, Currie BJ, Kaplan EL: Epidemiology and prevention of Group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the Twentieth Century. Clin Infect Dis. 1999, 28: 205-210.","journal-title":"Clin Infect Dis"},{"key":"145_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0950268898001952","volume":"122","author":"JR Carapetis","year":"1999","unstructured":"Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ: Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect. 1999, 122: 59-65. 10.1017\/S0950268898001952.","journal-title":"Epidemiol Infect"},{"key":"145_CR10","unstructured":"Trewin D: Population Distribution: Aboriginal and Torres Strait Islander Australians 2001\u20132002. Australian Bureau of Statistics, Canberra, Australia."},{"key":"145_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","volume":"269","author":"The Working Group on Severe Streptococcal Infections","year":"1993","unstructured":"The Working Group on Severe Streptococcal Infections: Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. JAMA. 1993, 269: 390-391. 10.1001\/jama.269.3.390.","journal-title":"JAMA"},{"key":"145_CR12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/jcm.34.4.953-958.1996","volume":"34","author":"B Beall","year":"1996","unstructured":"Beall B, Facklam R, Thompson T: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996, 34: 953-958.","journal-title":"J Clin Microbiol"},{"key":"145_CR13","unstructured":"Streptococcus pyogenes emm sequence database. [http:\/\/www.cdc.gov\/ncidod\/biotech\/strep\/strepblast.htm]"},{"key":"145_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1467-842X.2000.tb00134.x","volume":"24","author":"M Gracey","year":"2000","unstructured":"Gracey M, Williams P, Smith P: Aboriginal Deaths in Western Australia: 1985\u201389 and 1990\u201394. Aust N Z J Public Health. 2000, 24: 145-152.","journal-title":"Aust N Z J Public Health"},{"key":"145_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5694\/j.1326-5377.1996.tb124987.x","volume":"165","author":"J Cunningham","year":"1996","unstructured":"Cunningham J, Condon JR: Premature mortality in aboriginal adults in the Northern Territory, 1979\u20131991. Med J Aust. 1996, 165: 309-312.","journal-title":"Med J Aust"},{"key":"145_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0002-9610(96)00248-6","volume":"172","author":"B Sellers","year":"1996","unstructured":"Sellers B, Woods M, Morris S, Saffle J: Necrotizing group A streptococcal infections associated with streptococcal toxic shock syndrome. Am J Surg. 1996, 172: 523-528. 10.1016\/S0002-9610(96)00248-6.","journal-title":"Am J Surg"},{"key":"145_CR17","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1086\/317525","volume":"32","author":"T Simonart","year":"2001","unstructured":"Simonart T, Simonart JM, Derdelinckx I, De Dobbeleer G, Verleysen A, Verraes S, de Maubeuge J, Van Vooren JP, Naeyaert JM, de la Brassine M, Peetermans WE, Heenen M: Value of standard laboratory tests for the early recognition of group A \u03b2-haemolytic streptococcal necrotizing fasciitis. Clin Infect Dis. 2001, 32: e9-12. 10.1086\/317525.","journal-title":"Clin Infect Dis"},{"key":"145_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1072-7515(00)00318-5","volume":"191","author":"DB Wall","year":"2000","unstructured":"Wall DB, Klein SR, Black S, de Virgilio C: A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000, 191: 227-231. 10.1016\/S1072-7515(00)00318-5.","journal-title":"J Am Coll Surg"},{"key":"145_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00000658-198711000-00018","volume":"206","author":"L Sudarsky","year":"1987","unstructured":"Sudarsky L, Laschinger J, Coppa G, Spencer F: Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987, 206: 661-665.","journal-title":"Ann Surg"},{"key":"145_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0002-9610(83)90140-X","volume":"145","author":"J Majeski","year":"1983","unstructured":"Majeski J, Alexander J: Early diagnosis, nutritional support and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg. 1983, 145: 784-787. 10.1016\/0002-9610(83)90140-X.","journal-title":"Am J Surg"},{"key":"145_CR21","volume-title":"Antibiotic Therapeutic Guidelines: Antibiotic","author":"Writing Group for Therapeutic Guidelines","year":"2003","unstructured":"Writing Group for Therapeutic Guidelines: Antibiotic Therapeutic Guidelines: Antibiotic. 2003, Melbourne: Therapeutic Guidelines Ltd, 12","edition":"12"},{"key":"145_CR22","volume-title":"The Sanford Guide to Antimicrobial Therapy","author":"D Gilbert","year":"2002","unstructured":"Gilbert D, Moellering R, Sande M: The Sanford Guide to Antimicrobial Therapy. 2002, Hyde Park, VT: Antimicrobial Therapy Inc, 32","edition":"32"},{"key":"145_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/archinte.1985.00360060076010","volume":"145","author":"EM Adams","year":"1985","unstructured":"Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR: Streptococcal myositis. Arch Int Med. 1985, 145: 1020-1023. 10.1001\/archinte.145.6.1020.","journal-title":"Arch Int Med"},{"key":"145_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","volume":"13","author":"H Eagle","year":"1952","unstructured":"Eagle H: Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952, 13: 389-399. 10.1016\/0002-9343(52)90293-3.","journal-title":"Am J Med"},{"key":"145_CR25","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/infdis\/167.6.1401","volume":"167","author":"DL Stevens","year":"1993","unstructured":"Stevens DL, Yan S, Bryant AE: Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993, 167: 1401-1405.","journal-title":"J Infect Dis"},{"key":"145_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","volume":"158","author":"DL Stevens","year":"1988","unstructured":"Stevens DL, Bryant-Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988, 158: 23-28.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"145_CR27","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/clinids\/20.Supplement_2.S154","volume":"20","author":"DL Stevens","year":"1995","unstructured":"Stevens DL, Bryant AE, Hackett SP: Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis. 1995, 20 (Suppl 2): S154-157.","journal-title":"Clin Infect Dis"},{"key":"145_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","volume":"18","author":"J Zimbelman","year":"1999","unstructured":"Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999, 18: 1096-1100. 10.1097\/00006454-199912000-00014.","journal-title":"Pediatr Infect Dis J"},{"key":"145_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","volume":"96","author":"ZD Mulla","year":"2003","unstructured":"Mulla ZD, Leaverton PE, Wiersma ST: Invasive group A streptococcal infections in Florida. South Med J. 2003, 96: 968-973. 10.1097\/01.SMJ.0000051060.95210.9A.","journal-title":"South Med J"},{"key":"145_CR30","volume-title":"In: UpToDate? Version 11.1. UpToDate, Wellesley, MA","author":"CD O'Brien","year":"2003","unstructured":"O'Brien CD, Manaker S: Hyperbaric oxygen therapy. In: UpToDate? Version 11.1. UpToDate, Wellesley, MA. 2003"},{"key":"145_CR31","first-page":"203","volume":"5","author":"LA Clark","year":"1999","unstructured":"Clark LA, Moon RE: Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am. 1999, 5: 203-219.","journal-title":"Respir Care Clin N Am"},{"key":"145_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00000637-199708000-00004","volume":"39","author":"WA Zamboni","year":"1997","unstructured":"Zamboni WA, Mazolewski PJ, Erdmann D, Bergman BA, Hussman J, Cooper MD, Smoot EC, Russell RC: Evaluation of penicillin and hyperbaric oxygen in the treatment of streptococcal myositis. Ann Plast Surg. 1997, 39: 131-136.","journal-title":"Ann Plast Surg"},{"key":"145_CR33","first-page":"847","volume":"108","author":"JA Riseman","year":"1990","unstructured":"Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS: Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990, 108: 847-850.","journal-title":"Surgery"},{"key":"145_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0039-6060(05)80278-8","volume":"118","author":"A Shupak","year":"1995","unstructured":"Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S: Necrotizing fasciitis: an indication for hyperbaric oxygen therapy?. Surgery. 1995, 118: 873-878.","journal-title":"Surgery"},{"key":"145_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00001432-199806000-00004","volume":"11","author":"A Norrby-Teglund","year":"1998","unstructured":"Norrby-Teglund A, Stevens DL: Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response. Curr Opin Infect Dis. 1998, 11: 285-291.","journal-title":"Curr Opin Infect Dis"},{"key":"145_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/171.1.74","volume":"171","author":"R Watanabe-Ohnishi","year":"1995","unstructured":"Watanabe-Ohnishi R, Low D, McGeer A, Stevens DL, Schlievert PM, Newton D, Schwartz B, Kreiswirth B, Kotb M: Selective depletion of V\u03b2-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis. 1995, 171: 74-84.","journal-title":"J Infect Dis"},{"key":"145_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/infdis\/166.1.31","volume":"166","author":"SE Holm","year":"1992","unstructured":"Holm SE, Norrby A, Bergholm A, Norgren M: Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988\u20131989. J Infect Dis. 1992, 166: 31-37.","journal-title":"J Infect Dis"},{"key":"145_CR38","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","volume":"156","author":"A Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, Andersson U, Kotb M: Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996, 156: 3057-3064.","journal-title":"J Immunol"},{"key":"145_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1086\/323443","volume":"184","author":"A Norrby-Teglund","year":"2001","unstructured":"Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE: Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis. 2001, 184: 853-860. 10.1086\/323443.","journal-title":"J Infect Dis"},{"key":"145_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, StreptIg Study Group: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003, 37: 333-340. 10.1086\/376630.","journal-title":"Clin Infect Dis"},{"key":"145_CR41","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1001\/jama.1992.03480240077038","volume":"267","author":"W Barry","year":"1992","unstructured":"Barry W, Hudgins L, Donta S, Pesanti E: Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992, 267: 3315-3316. 10.1001\/jama.267.24.3315.","journal-title":"JAMA"},{"key":"145_CR42","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(94)92548-8","volume":"343","author":"JM Yong","year":"1994","unstructured":"Yong JM: Necrotizing fasciitis. Lancet. 1994, 343: 1427-10.1016\/S0140-6736(94)92548-8.","journal-title":"Lancet"},{"key":"145_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1086\/514585","volume":"26","author":"DL Stevens","year":"1998","unstructured":"Stevens DL: Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis. 1998, 26: 639-641.","journal-title":"Clin Infect Dis"},{"key":"145_CR44","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/167.5.1112","volume":"167","author":"DR Martin","year":"1993","unstructured":"Martin DR, Single LA: Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis. 1993, 167: 1112-1117.","journal-title":"J Infect Dis"},{"key":"145_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/infdis\/169.3.519","volume":"169","author":"H Seppala","year":"1994","unstructured":"Seppala H, Vuopio-Varkila J, Osterblad M, Jahkola M, Rummukainen M, Holm SE, Huovinen P: Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis. 1994, 169: 519-525.","journal-title":"J Infect Dis"},{"key":"145_CR46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/iai.63.3.994-1003.1995","volume":"63","author":"JM Musser","year":"1995","unstructured":"Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR: Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: Recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun. 1995, 63: 994-1003.","journal-title":"Infect Immun"},{"key":"145_CR47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1099\/0022-1317-49-5-467","volume":"49","author":"P Descheemaeker","year":"2000","unstructured":"Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P, Goossens H: Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993\u20131994. J Med Microbiol. 2000, 49: 467-471.","journal-title":"J Med Microbiol"},{"key":"145_CR48","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1128\/JCM.41.11.4941-4949.2003","volume":"41","author":"BJ Vlaminckx","year":"2003","unstructured":"Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J, Schmitz FJ: Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol. 2003, 41: 4941-4949. 10.1128\/JCM.41.11.4941-4949.2003.","journal-title":"J Clin Microbiol"},{"key":"145_CR49","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1128\/IAI.68.6.3523-3534.2000","volume":"68","author":"S Chatellier","year":"2000","unstructured":"Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M: Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun. 2000, 68: 3523-3534. 10.1128\/IAI.68.6.3523-3534.2000.","journal-title":"Infect Immun"},{"key":"145_CR50","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/infdis\/173.4.901","volume":"173","author":"MS Chaussee","year":"1996","unstructured":"Chaussee MS, Liu J, Stevens DL, Ferretti JJ: Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis. 1996, 173: 901-908.","journal-title":"J Infect Dis"},{"key":"145_CR51","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1128\/JCM.41.10.4655-4659.2003","volume":"41","author":"AE Moses","year":"2003","unstructured":"Moses AE, Hidalgo-Grass C, Dan-Goor M, Jaffe J, Shetzigovsky I, Ravins M, Korenman Z, Cohen-Poradosu R, Nir-Paz R: emm typing of M nontypeable invasive group A streptococcal isolates in Israel. J Clin Microbiol. 2003, 41: 4655-4659. 10.1128\/JCM.41.10.4655-4659.2003.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2334-4-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:44:24Z","timestamp":1728305064000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-4-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-4-60","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,16]]},"assertion":[{"value":"30 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}